Skip to main content
. 2009 Aug 20;4(8):e6703. doi: 10.1371/journal.pone.0006703

Table 2. ERA PB phospho-signaling is distinguished from OA PB in the CD4+ and CD20+ cell populations.

Phospho-signaling effector CD4+* CD8+* CD20+*
p-AKT 50% 0% 40%
p-BTK 50% 0% 40%
p-CBL 60% 0% 40%
p-JNK 50% 0% 0%
p-PLCγ 60% 0% 40%
p-STAT1 50% 0% 40%
p-STAT3 40% 0% 0%
p-STAT6 40% 0% 40%
p-ZAP70 50% 0% 40%
*

Percentage of ERA patients with MFI values ≥10% above the maximum level recorded in the OA patient cohort is denoted.